| || On comparing cytokine levels in auranofin and DMSO-treated cells at 24 and 48 h, SARS-CoV-2-induced cytokines was found in significantly lower levels in auranofin treated cells.
|Title ||The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells|
|Author(s) name||Rothan HA, Stone S, Natekar J, Kumari P, Arora K, Kumar M. |
|Citation count||20 |
|Date of publishing||2020 Aug|